Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 11: Hepatic secretory function is evaluated using which of the following parameters?

A. Alkaline phosphatase
B. 5' nucleotidase
C. Gamma glutamyl transpeptidase
D. Prothrombin time (PT) (Correct Answer)

Explanation: **Explanation:** Liver function tests (LFTs) are categorized based on the specific physiological process they evaluate: synthetic function, excretory (secretory) function, or hepatocyte integrity. **Why Prothrombin Time (PT) is the Correct Answer:** The liver is responsible for the synthesis of almost all coagulation factors (except Factor VIII and von Willebrand factor). **Prothrombin Time (PT)** measures the extrinsic and common pathways of coagulation. Because these factors are synthesized and then **secreted** into the systemic circulation, PT is a sensitive marker of the liver's **secretory and synthetic capacity**. Since Factor VII has a very short half-life (approx. 6 hours), PT is an excellent indicator of acute liver dysfunction. **Why Other Options are Incorrect:** * **A, B, and C (ALP, 5' Nucleotidase, and GGT):** These are markers of **cholestasis** or biliary tract obstruction. While they relate to the "excretion" of bile, in clinical biochemistry, they are classified as markers of **biliary epithelial integrity** or obstructive jaundice rather than the liver's global secretory/synthetic output into the blood. Specifically, ALP and GGT are enzymes that increase due to induction or leakage from the bile duct epithelium. **High-Yield Clinical Pearls for NEET-PG:** * **Best marker for Acute Liver Failure:** Prothrombin Time (PT/INR) is more sensitive than Albumin because Albumin has a long half-life (20 days). * **True Liver Function Tests:** Only PT/INR and Albumin truly reflect the liver's metabolic/synthetic work. Enzymes (ALT/AST) reflect **cell injury**, not function. * **GGT:** The most sensitive marker for **alcoholic liver disease** and helpful in differentiating the source of elevated ALP (GGT is normal in bone disease). * **5' Nucleotidase:** Highly specific for hepatobiliary disease; used to confirm that an elevated ALP is of hepatic origin.

Question 12: Which of the following best assesses the quantitative function of the liver?

A. Degree of transaminases
B. Degree of alkaline phosphatase
C. Galactose metabolism (Correct Answer)
D. All the above

Explanation: **Explanation:** In clinical biochemistry, it is crucial to distinguish between tests that indicate **hepatocyte injury** and those that measure **true liver function (quantitative function)**. **Why Galactose Metabolism is correct:** The liver is the primary site for galactose metabolism (via the Leloir pathway). The **Galactose Elimination Capacity (GEC)** test is a quantitative dynamic liver function test. Since the metabolism of galactose is almost entirely dependent on the functional hepatocyte mass and is independent of liver blood flow (at high concentrations), the rate at which the liver clears galactose directly reflects its **functional metabolic capacity**. It is a better predictor of prognosis in chronic liver disease than static markers. **Why other options are incorrect:** * **Transaminases (ALT/AST):** These are markers of **hepatocellular injury** (leakage enzymes). While they indicate that damage is occurring, they do not quantify how much functional liver tissue remains. For example, in end-stage cirrhosis, transaminases may be near normal because there are few hepatocytes left to leak enzymes. * **Alkaline Phosphatase (ALP):** This is a marker of **cholestasis** or biliary obstruction, not a measure of the liver's metabolic or synthetic capacity. **NEET-PG High-Yield Pearls:** * **Static Tests:** Bilirubin, Albumin, and Prothrombin Time (PT). PT is the best indicator of *acute* synthetic function due to the short half-life of Factor VII. * **Dynamic/Quantitative Tests:** Galactose Elimination Capacity, Aminopyrine breath test, and Indocyanine Green (ICG) clearance. * **True Function:** Only synthetic (Albumin/Clotting factors) and metabolic/excretory (Galactose/Bilirubin) tests assess "function." Transaminases only assess "integrity."

Question 13: Which biochemical marker is most specific for alcoholic liver disease?

A. AST (Aspartate Aminotransferase)
B. ALT (Alanine Aminotransferase)
C. GGT (Gamma-Glutamyl Transferase) (Correct Answer)
D. ALP (Alkaline Phosphatase)

Explanation: **Explanation:** **Gamma-Glutamyl Transferase (GGT)** is the most sensitive and specific biochemical marker for alcoholic liver disease. The primary reason is that alcohol acts as a potent **enzyme inducer** of GGT in the hepatocytes. Even in the absence of significant liver cell damage, chronic alcohol consumption leads to elevated GGT levels. Furthermore, GGT is particularly useful in distinguishing whether an elevated Alkaline Phosphatase (ALP) is of hepatic or bony origin, as GGT is not found in bone. **Analysis of Incorrect Options:** * **AST (Aspartate Aminotransferase):** While AST is typically higher than ALT in alcoholic hepatitis (the classic **AST:ALT ratio > 2:1**), AST is not specific to the liver; it is also found in cardiac muscle, skeletal muscle, and RBCs. * **ALT (Alanine Aminotransferase):** ALT is more specific to the liver than AST, but it is often **low or normal** in alcoholic liver disease because alcoholics are frequently deficient in **Pyridoxal-5-phosphate (Vitamin B6)**, a necessary co-factor for ALT synthesis. * **ALP (Alkaline Phosphatase):** This is a marker of cholestasis or bone turnover. While it may rise in alcoholic cirrhosis, it lacks the specificity for alcohol induction seen with GGT. **High-Yield Clinical Pearls for NEET-PG:** * **AST:ALT Ratio:** A ratio > 2:1 is highly suggestive of alcoholic liver disease ("**S**" in AST stands for "**S**cotch"). * **Isolated GGT elevation:** Often the first sign of occult alcohol abuse in an otherwise asymptomatic patient. * **MCV Connection:** In chronic alcoholics, elevated GGT is often accompanied by an **increased Mean Corpuscular Volume (Macrocytosis)** due to direct bone marrow toxicity or folate deficiency.

Question 14: What does the HbA1c level in blood explain?

A. Acute rise of blood sugar
B. Long-term status of blood sugar (Correct Answer)
C. Hepatorenal syndrome
D. Chronic pancreatitis

Explanation: **Explanation:** **HbA1c (Glycated Hemoglobin)** is the gold standard for monitoring glycemic control in diabetic patients. The correct answer is **B (Long-term status of blood sugar)** because of the underlying biochemical process of **non-enzymatic glycation**. 1. **Mechanism:** Glucose in the blood binds covalently and irreversibly to the N-terminal valine of the beta chain of hemoglobin. Since red blood cells (RBCs) have an average lifespan of **120 days**, the HbA1c level reflects the average blood glucose concentration over the preceding **2–3 months**. 2. **Why other options are incorrect:** * **Option A:** Acute rises in blood sugar are monitored via Fasting Blood Sugar (FBS) or Post-Prandial Blood Sugar (PPBS). HbA1c is not sensitive to daily fluctuations. * **Options C & D:** While chronic pancreatitis can lead to secondary diabetes, HbA1c is a marker of glucose control, not a diagnostic test for the underlying organ pathology of the liver, kidney, or pancreas itself. **High-Yield Clinical Pearls for NEET-PG:** * **Normal Range:** 4% – 5.6%. * **Prediabetes:** 5.7% – 6.4%. * **Diabetes Diagnosis:** ≥ 6.5% (as per ADA criteria). * **False Lows:** Conditions with high RBC turnover (e.g., Hemolytic anemia, recent blood loss, or pregnancy) will falsely decrease HbA1c levels. * **False Highs:** Conditions that increase RBC lifespan (e.g., Iron deficiency anemia, Splenectomy) can falsely elevate HbA1c. * **Fructosamine Test:** Used to monitor glucose over 2–3 weeks (useful when HbA1c is unreliable).

Question 15: Which of the following does NOT cause a false positive D-xylose test?

A. Bacterial overgrowth
B. Renal failure
C. Ascites
D. Celiac sprue (Correct Answer)

Explanation: The **D-xylose absorption test** is used to differentiate between malabsorption caused by intestinal mucosal disease and malabsorption due to pancreatic insufficiency. D-xylose is a monosaccharide that does not require pancreatic enzymes for digestion; it is absorbed directly by the proximal small intestine and excreted unchanged by the kidneys. ### Why Celiac Sprue is the Correct Answer In **Celiac sprue**, there is actual mucosal damage (villous atrophy). This leads to decreased absorption of D-xylose, resulting in low blood levels and low urinary excretion. This is a **true positive** result for intestinal malabsorption. The question asks for what does *not* cause a false positive; since Celiac sprue causes a true positive, it is the correct choice. ### Explanation of False Positives (Incorrect Options) A "false positive" occurs when the test suggests mucosal disease (low urinary D-xylose) even though the intestinal mucosa is actually healthy. * **Bacterial Overgrowth (SIBO):** Intestinal bacteria metabolize D-xylose before it can be absorbed, leading to low urinary levels despite normal mucosa. * **Renal Failure:** Since D-xylose is excreted by the kidneys, impaired renal function prevents it from appearing in the urine, even if absorption was normal. * **Ascites:** D-xylose is a water-soluble sugar that can sequester into third-space fluids (like ascitic fluid), reducing the amount available for renal excretion. ### High-Yield Clinical Pearls for NEET-PG * **Primary Use:** To distinguish **Mucosal disease** (Low D-xylose) from **Pancreatic insufficiency** (Normal D-xylose). * **Normal Values:** Typically, a 25g oral dose should result in >4g excreted in the urine over 5 hours. * **Delayed Gastric Emptying:** Can also cause a false positive result. * **Age Factor:** Elderly patients may have naturally lower urinary excretion due to a physiological decline in GFR.

Question 16: Serum amylase level is raised in all conditions except?

A. Blocked salivary duct
B. Ruptured ectopic pregnancy
C. Appendicitis (Correct Answer)
D. Pancreatitis

Explanation: **Explanation:** Serum amylase is an enzyme primarily produced by the **pancreas** (P-isoamylase) and **salivary glands** (S-isoamylase), with smaller contributions from the fallopian tubes and small intestine. **Why Appendicitis is the correct answer:** In uncomplicated **appendicitis**, there is typically no significant involvement of the pancreas, salivary glands, or fallopian tubes. Therefore, serum amylase levels remain within the normal range. While some intra-abdominal inflammatory conditions can cause a mild rise, appendicitis is classically the "except" in this list as it does not typically manifest with hyperamylasemia. **Analysis of Incorrect Options:** * **Pancreatitis:** This is the most common cause of elevated amylase. Inflammation leads to the leakage of P-isoamylase into the bloodstream, often reaching levels >3 times the upper limit of normal. * **Blocked Salivary Duct:** Conditions like sialolithiasis or mumps cause a backup of S-isoamylase, which is then absorbed into the systemic circulation, raising total serum amylase. * **Ruptured Ectopic Pregnancy:** The fallopian tubes contain high concentrations of amylase. Rupture leads to the release of this enzyme into the peritoneal cavity and subsequent absorption into the blood. **High-Yield Clinical Pearls for NEET-PG:** * **Amylase vs. Lipase:** Serum lipase is more **specific** for acute pancreatitis than amylase and remains elevated longer (7–14 days vs. 3–5 days for amylase). * **Macroamylasemia:** A benign condition where amylase binds to Immunoglobulins (IgA/IgG), becoming too large to be filtered by the kidneys, leading to high serum amylase but **low urinary amylase**. * **Other causes of high amylase:** Perforated peptic ulcer, intestinal obstruction, and mesenteric ischemia (due to leakage from the gut lumen).

Question 17: What is the mechanism of action of allopurinol?

A. Inhibits the synthesis of uric acid (Correct Answer)
B. Inhibits the tubular resorption of uric acid
C. Has anti-inflammatory action
D. Increases phagocytosis of urate crystals

Explanation: **Explanation:** **Mechanism of the Correct Answer:** Allopurinol is a structural analog of hypoxanthine. It acts as a **competitive inhibitor of Xanthine Oxidase**, the key enzyme responsible for converting hypoxanthine to xanthine and xanthine to **uric acid**. Furthermore, allopurinol is metabolized by xanthine oxidase into **Alloxanthine (Oxypurinol)**, which acts as a non-competitive, suicide inhibitor of the same enzyme. By blocking this pathway, allopurinol directly **inhibits the synthesis of uric acid**, leading to a decrease in serum and urinary uric acid levels. **Analysis of Incorrect Options:** * **Option B:** Drugs that inhibit the tubular reabsorption of uric acid (increasing excretion) are called **Uricosurics** (e.g., Probenecid, Sulfinpyrazone, Benzbromarone). * **Option C & D:** These describe the mechanisms of drugs used in acute gout. **Colchicine** inhibits microtubule polymerization, thereby decreasing the migration and **phagocytosis of urate crystals** by neutrophils. NSAIDs and Steroids provide anti-inflammatory relief. Allopurinol has no analgesic or anti-inflammatory properties. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Allopurinol is the DOC for **Chronic Gout** and for preventing **Tumor Lysis Syndrome** (Hyperuricemia secondary to chemotherapy). * **Acute Flare-up:** Allopurinol should **never** be started during an acute attack of gout, as a sudden drop in serum urate can mobilize crystals from tissues, worsening the inflammation. * **Drug Interaction:** It significantly increases the toxicity of **6-Mercaptopurine** and **Azathioprine** because these drugs are normally metabolized by xanthine oxidase. Doses of these drugs must be reduced by 75% if given with allopurinol.

Question 18: Which of the following statements regarding alpha-fetoprotein is true?

A. Its major source in fetal life is the yolk sac. (Correct Answer)
B. It is commonly increased in Wilms' tumor.
C. It reaches maximum levels around the 20th week of gestation.
D. Its half-life is approximately 5-7 days.

Explanation: **Explanation:** **Alpha-fetoprotein (AFP)** is a glycoprotein synthesized during fetal life that serves as the fetal analog of albumin. 1. **Why Option A is correct:** During early embryonic development, the **yolk sac** is the primary source of AFP. As gestation progresses, the **fetal liver** takes over as the major site of synthesis, with small amounts also produced by the fetal gastrointestinal tract. 2. **Why other options are incorrect:** * **Option B:** AFP is a classic tumor marker for **Hepatocellular Carcinoma (HCC)** and **Non-seminomatous germ cell tumors (Yolk sac tumors)**. It is *not* typically elevated in Wilms' tumor (Nephroblastoma); the marker associated with Wilms' is often cited as hyaluronic acid or specific genetic mutations (WT1). * **Option C:** In maternal serum, AFP levels peak around the **30th–32nd week** of gestation. In fetal serum, however, levels peak much earlier, at the end of the **first trimester (approx. 12–14 weeks)**, and decline thereafter. * **Option D:** The biological half-life of AFP is approximately **5 to 7 days**. While Option D is technically close, in the context of standard medical examinations, Option A is the definitive physiological fact regarding its origin. *(Note: Some texts cite 5 days; however, the yolk sac origin is a higher-yield physiological fact).* **High-Yield Clinical Pearls for NEET-PG:** * **Elevated Maternal Serum AFP (MSAFP):** Seen in Neural Tube Defects (NTDs) like spina bifida and anencephaly, abdominal wall defects (omphalocele, gastroschisis), and multiple pregnancies. * **Decreased MSAFP:** Characteristically seen in **Down Syndrome (Trisomy 21)** and Edwards Syndrome. * **Tumor Marker:** AFP >500 ng/mL in an adult is highly suggestive of Hepatocellular Carcinoma.

Question 19: Which marker is considered the best for detecting cardiac events?

A. High-sensitivity C-reactive protein (hsCRP) (Correct Answer)
B. Homocysteine levels
C. Interleukin-6
D. P-selectin

Explanation: **Explanation:** **1. Why hsCRP is the Correct Answer:** High-sensitivity C-reactive protein (hsCRP) is a marker of systemic inflammation, which plays a critical role in the pathogenesis of atherosclerosis and plaque rupture. Unlike standard CRP, the **hsCRP** assay can detect very low levels of inflammation. It is considered the best marker among the options for **predicting future cardiovascular events** (MI, stroke, or peripheral vascular disease) in asymptomatic individuals. According to the AHA/CDC guidelines, hsCRP levels categorize risk as: Low (<1 mg/L), Average (1–3 mg/L), and High (>3 mg/L). **2. Why Other Options are Incorrect:** * **Homocysteine:** While elevated levels (Hyperhomocysteinemia) are associated with endothelial damage and increased risk of thrombosis, it is considered a secondary risk factor and lacks the predictive strength and clinical standardization of hsCRP. * **Interleukin-6 (IL-6):** IL-6 is a pro-inflammatory cytokine that stimulates the liver to produce CRP. While it is upstream in the inflammatory cascade, it has a short half-life and high analytical variability, making it less suitable for routine clinical screening than hsCRP. * **P-selectin:** This is an adhesion molecule expressed on activated platelets and endothelium. While it indicates platelet activation and vascular injury, it is not a routine clinical marker for predicting cardiac events. **3. High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard for Acute MI:** Cardiac Troponins (I and T) are the markers of choice for *diagnosis* of an acute event. * **Early Marker:** Myoglobin is the earliest marker to rise (1–2 hours) but is non-specific. * **Re-infarction:** CK-MB is the marker of choice for detecting a second MI within the first week because it returns to baseline within 48–72 hours. * **Prognostic Value:** hsCRP is specifically used for **risk stratification** in primary prevention, not for the acute diagnosis of an ongoing MI.

Question 20: Metalloproteins help in jaundice by which mechanism?

A. Increased glucoronyl transferase activity
B. Inhibition of heme oxygenase (Correct Answer)
C. Decreased red blood cell lysis
D. Increased Y and Z receptors

Explanation: **Explanation:** The correct answer is **B. Inhibition of heme oxygenase.** **Mechanism of Action:** Metalloporphyrins (such as **Tin-mesoporphyrin** or **Zinc-protoporphyrin**) are synthetic analogs of heme. They act as potent competitive inhibitors of **Heme Oxygenase**, the rate-limiting enzyme in the bilirubin synthesis pathway. Heme oxygenase normally breaks down heme into biliverdin, which is then converted to bilirubin. By inhibiting this enzyme, metalloporphyrins decrease the production of bilirubin at its source, thereby reducing serum bilirubin levels. This is particularly useful in managing neonatal hyperbilirubinemia. **Analysis of Incorrect Options:** * **Option A:** Glucuronyl transferase activity is increased by drugs like **Phenobarbital**, which induces the UGT1A1 enzyme to enhance bilirubin conjugation. * **Option C:** Decreased RBC lysis (stabilizing the RBC membrane) is not the mechanism of metalloproteins; this would relate more to treating hemolytic anemias. * **Option D:** Y and Z receptors (Ligandins) are responsible for the hepatic uptake of bilirubin. Their expression is naturally low in neonates and increases with age, but is not the target of metalloporphyrin therapy. **High-Yield Clinical Pearls for NEET-PG:** * **Rate-limiting enzyme of bilirubin synthesis:** Heme Oxygenase. * **Rate-limiting enzyme of bilirubin conjugation:** UDP-Glucuronyl Transferase (UGT1A1). * **Tin-mesoporphyrin (SnMP):** The most commonly studied metalloporphyrin for preventing severe jaundice in newborns with ABO or Rh incompatibility. * **Phototherapy vs. Metalloproteins:** While phototherapy breaks down existing bilirubin (photoisomerization), metalloproteins prevent the *formation* of bilirubin.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free